Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 290-476-8 | CAS number: 90170-43-7
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- other: Review
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Review of historical data
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- no guideline required
- Guideline:
- other: Assessment
- Test type:
- other: Review
Test material
- Reference substance name:
- β-Alanine, N-(2-carboxyethyl)-, N-coco alkyl derivs., disodium salts
- EC Number:
- 290-476-8
- EC Name:
- β-Alanine, N-(2-carboxyethyl)-, N-coco alkyl derivs., disodium salts
- Cas Number:
- 90170-43-7
- IUPAC Name:
- β-Alanine, N-(2-carboxyethyl)-, N-coco alkyl derivs., disodium salts
Constituent 1
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- discriminating dose
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- act. ingr.
- Remarks on result:
- other: Estimated
- Mortality:
- No evidence of mortality from dermal contact
- Clinical signs:
- other: None reported
- Other findings:
- Local irritation noted in some sources of information
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- No evidence of dermal toxicity, although some local effects to the skin due to irritation. The supporting data is very weak, but there is considered to be no justification to perform new animal studies. A waiver is requested. The subtance is widely supplied ot the cosmetics industry and new testing has not been considered appropriate.
Read-across justified by statement claiming the data covers range of alklyimines; specifically, "sodium and potassium salts of N-alkyl
(C8-C18)-beta-iminodipropionic acid where the C8-C18 is linear and may be saturated and/or unsaturated, (CAS Reg. Nos. 110676-19-2, 3655-00-3, 61791-56-8, 14960-06-6, 26256-79-1, 90170-43-7, 91696-17-2, and 97862-48-1) [Ref 40 CFR Part 180, Federal Register Volume 76, number 24, 4 February 2011'
The only significant source of information found included the Industrial Bio-Test laboratories report on 10% Deriphat 160-C from 1963 (cited above) in which a 10% solution is dosed at up to 10.2 g/kg (1020 mg/kg actives) on rabbits with no adverse effects reported.
There is no evidence of dermal toxicity other than local irritant effects in any substances of this class.
The EPA review of Sodium and Potassium Salts of N-alkyl (C8-C18)-beta-iminodipropionic acid [2] concludes that there is low toxicity and in the opinion of the US EPA, no further testing is needed. - Executive summary:
References:
International Journal of Toxicology, 16 (Suppl) 1):1-9 1997
Cosmetic Ingredient Review, Meetings December 12 -13 2011
SSNA Inert Ingredients Human Health Risk Assessment, US Environmental Protection Agency report D365994, 10 June 2009
Read-across justified by statement claiming the data covers range of alklyimines; specifically, "sodium and potassium salts of N-alkyl (C8-C18)-beta-iminodipropionic acid where the C8-C18 is linear and may be saturated and/or unsaturated, (CAS Reg. Nos. 110676-19-2, 3655-00-3, 61791-56-8, 14960-06-6, 26256-79-1, 90170-43-7, 91696-17-2, and 97862-48-1) [Ref 40 CFR Part 180, Federal Register Volume 76, number 24, 4 February 2011'
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
